Multiple Sclerosis Ireland

Lobbying Organisation Multiple Sclerosis Ireland

Date published 20 Jan, 2019

Relevant Matter Matters involving public funds

Public Policy Area Health

Period 1 Sep, 2018 to 31 Dec, 2018

Specific Details Access to Ocrelizumab

Intended results Requesting an update on when people who are eligible for this medication can expect to gain access to it.

Name of person primarily responsible for lobbying on this activity Thomas McCarthy

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) Yes

Current or Former Designated Public Official(s)

Donnchadh O'Laoghaire (Currently employed as a DPO) TD (Dáil Éireann, the Oireachtas)

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Email (1)

Emailed Deputy Donnchadh O'Laoghaire requesting that he raise a parliamentary question for Minister Simon Harris asking if the application for the reimbursement of Ocrelizumab has been discussed by the HSE Drugs Group and when eligible people living with MS can expect to gain access to the drug.

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Simon Harris TD (Dáil Éireann, the Oireachtas)